Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxie Read More Post navigation As quarantine rules ease, intellectual property filings rise UMC Achieves AA Certification for Excellence in Intellectual Property Management and Protection
Webinar on ‘The Proposal to Amend the Indian Patents Act: Adverse Implications for Access to Medicines’ [June 2] Jun 1, 2023
Hear Me Out! Assessment of Phonetic Similarity is as Important as that of Visual Similarity: An Assessment of INSEAD v. Fullstack Education May 30, 2023
